
    
      The purpose of this study is to evaluate the safety and tolerability of 14 once daily
      intravenous (IV) infusions of ascending doses of AVI 7288 compared to matched placebo in
      healthy male and female subjects.

      To evaluate the pharmacokinetics (PK) of 14 once daily doses of AVI-7288 in healthy male and
      female subjects
    
  